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Vaccine hesitancy remains a problem. Patrick Sturgis (LSE), Ian Brunton-Smith
(University of Surrey) and Jonathan Jackson (LSE)  nd that people who live in
societies where trust in science is high are more con dent about vaccination.
While there is much that we are yet to understand about the coronavirus, on one issue
there is near universal agreement amongst experts – we will not return to normal life
until the majority of the world’s population has been vaccinated. An intense effort is
now underway to deliver this objective, and a number of countries, including the UK,
have already vaccinated a majority of their people.
Up until now, the focus of attention has been on obtaining stocks of vaccines, as
national governments vie to maximise their share of a limited global supply. Yet in the
months ahead it seems likely that concern will shift from supply to demand, as the
willing are inoculated and those still to receive the vaccine are hesitant or unwilling to
take it. Vaccine hesitancy and refusal matter because, unlike other medicines,
vaccines work at both the individual and the societal levels. Without achieving high
rates of immunisation, the coronavirus is likely to remain an endemic threat. While the
exact threshold is yet to be determined, it seems likely that countries will need to
achieve a vaccination rate of over 70% to attain ‘herd immunity’.
Worryingly, survey evidence suggests that substantial minorities in many countries will
refuse to be vaccinated. For example, a survey by Imperial College London in
November 2020 found only minorities reporting they would de nitely get vaccinated
against COVID in Canada, Germany, Japan, Singapore, and France. More recent
evidence suggests that hesitancy may be declining as the rollout progresses, but the
recent emergence of rare side-effects and the suspension of the AstraZeneca and
Johnson & Johnson vaccines in some countries seem likely to raise doubts in the
minds of the unvaccinated. Addressing vaccine hesitancy is likely, then, to be at the
forefront of the next stage of the battle against COVID.
In our new article published in the journal Nature Human Behavior we investigate how
trust in science drives vaccine con dence, using a unique global survey of public
attitudes to science, the 2018 Wellcome Global Monitor, which covers over 120,000
people in 126 countries. Until now, attention to vaccine con dence has focused
almost entirely on individual level trust within single country contexts, with a wealth of
evidence that trust in science serves as a key psychological factor underpinning
vaccine acceptance. Thinking through the rights and wrongs—the bene ts, risks and
hazards—of vaccination may take a good deal of (error-prone) effort, especially if one
has little knowledge and experience of the issues involved. So people rely instead on
the ‘cognitive shortcut’ of trust (or mistrust) in science and scientists.
People queue outside a vaccination centre in Latvia on 16 April 2021. Photo: Dāvis
Kļaviņš via a CC BY NC SA 2.0 licence
What is new about our research is that we consider the role of societal level trust in
science. We ask whether people living in societies with a higher level of trust in
science are more con dent about vaccination, over and above their own individual
level of trust. And, in addition to considering country-level differences in average levels
of trust in science, we also assess the role of societal consensus about it. People who
live in countries with a strong supportive culture for science will (a) be more likely to
trust science and (b) rely more heavily on trust as a decision heuristic. This helps them
reach a position on vaccination that aligns more strongly with the dominant normative
view around the scienti c and regulatory systems that underpin vaccination
programmes.
Findings from the Wellcome Global
Monitor survey
The 2018 Wellcome Global Monitor reveals a high level of trust in science globally,
with more than four  fths reporting ‘some’ or ‘a lot’ of trust in science, and similar
numbers reporting this level of trust in scientists (85%) and their ability to  nd out
accurate information about the world (85%). Trust in science is highest in North
America, Western Europe, and Australasia and lowest in South America, Eastern
Europe, and Africa.
Figure 1: Percentage trusting science ‘some’ or ‘a lot’
Note: Countries shaded grey were not included in the Wellcome Global Monitor survey.
Con dence in vaccines is even higher, with 93% globally that vaccines are important
for children to have, 81% globally agreeing that vaccines are safe, and 86% that
vaccines are effective. The highest levels of vaccine con dence are found in Africa
and parts of Asia, and the lowest levels in Eastern Europe.
Figure 2: Percentage agreeing vaccines are effective
Note: Countries shaded grey were not included in the Wellcome Global Monitor survey.
There is also a lot of variation between countries in the level of social consensus
about whether science can be trusted. The  gure below shows within-country
standard deviations for trust in science, which we use to summarise the degree of
social consensus. Note that (somewhat confusingly) higher scores here indicate more
within-country variability and, therefore, a weaker social consensus on trust in science.
The Czech Republic has the lowest social consensus, with Guinea, Romania,
Botswana and the United Arab Emirates also showing particularly low levels of
agreement about whether science can be trusted. At the other end of the spectrum,
Thailand, Latvia, Togo, Iran, Nepal, Italy, and Japan are the countries with the highest
national consensus on trust in science.
Figure 3: Variation in social consensus that science can be trusted across 122
countries
We assess whether this variability in consensus across countries shapes the
relationship between trust in science and vaccine con dence, at both the individual
and societal levels. We  nd that people in countries with higher average levels of trust
in science are also more con dent about vaccination, even accounting for the well-
established positive effect of individual level trust in science. We also show that
relationships between scienti c trust and vaccine con dence are moderated by the
strength of societal consensus around trust in science – at higher levels of consensus
that science is trustworthy, the association between trust and vaccine con dence is
greater for both individual and country level trust in science.
This moderating effect can be seen in the  gure below which plots the association
between country level trust in science (x axis) and individual level vaccine con dence
(y axis) at different quintiles (Q1 to Q5) of societal consensus. Within countries, trust
in science is positively related to vaccine con dence only when social consensus
around trust in science is strong (left hand panels). In countries where consensus is
weaker (right hand panels), trust in science is not signi cantly associated with vaccine
con dence.
Figure 4: Societal consensus moderates the relationship between trust in science and
support for vaccines
The same moderating effect of social consensus is also evident in the  gure below for
individual-level trust within countries, albeit to a lesser extent. The effect of individual
trust in science on vaccine con dence is weaker when there is less societal
consensus that science and scientists can be trusted.
Figure 5: The effect of individual trust in science is weaker when there is less societal
consensus that science can be trusted
The importance of societal context
As with the protective effects of vaccines, public con dence in immunisation
programmes is underpinned by factors operating at the societal as well as the
individual level. In countries where trust in science is high, people are also more
con dent about vaccination, and in countries where consensus that science and
scientists can be trusted is high, the effect of trust in science on vaccination
con dence is stronger. This moderating effect is apparent when considering both the
between and the within country association between trust in science and vaccine
con dence.
Our  ndings point to the importance of looking beyond individual level drivers of
vaccine con dence. Trust in science seems to be most powerful in shaping
vaccination con dence when there is a normative consensus around the value of
science in one’s country. Just as immunisation works at the population level—the more
widespread the uptake the better—so it seems that trust in science is most effective in
fostering vaccination con dence when it is widely agreed upon in society. A crucial
area for future research will be to identify which factors contribute to the production of
societal consensus around trust in science, to inform effective public communication
strategies around vaccination programmes.
This post represents the views of the authors and not those of the COVID-19 blog, nor
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